1 Exporting genome data interpretation services to the worldAbomics Oy Exporting genome data interpretation services to the world

2 Markkinamahdollisuudet ja verkostointi- kiinni parhaisiin mahdollisuuksiin ja oikeisiin kumppaneihin Abomics Oy – interpretating genetic tests for laboratories and providing information services for health care professionals and patients 2 Japanese university hospitals are testing Abomics’ databases. Based on the pilot project, Fujitsu will decide whether to sell them. 1>10 M€ Abomics is aiming for fast turnover growth in the next few years 2016 Abomics signed an agreement with Synlab, the biggest provider of laboratory services in Europe 30+ countries, where Synlab operates, offer excellent growth prospects for Abomics Challenge: Opening new international markets Solution: Abomics has participated in Finpro’s export promotion trips, for example to Japan. Results: “Finpro has invited Fujitsu’s executives to the receptions of the Finnish ambassador and this has been much appreciated by Fujitsu. It has supported our negotiations with Fujitsu. As a pilot project Fujitsu has trained its own personnel to demonstrate Abomics’ databases to its customers in Japanese hospitals.” Jari Forsström Toimitusjohtaja Abomics Oy Founded in 2013 in Turku, Abomics Oy specializes in translating genomics research into clinical practice. The ICT solutions developed by Abomics make it possible to tailor treatment according to an individual patient’s genome. Abomics has participated in Finpro’s trips to the United States, Saudi Arabia, Dubai and Japan. Networking event organised by Finpro in Japan have supported Abomics’ negotiations with Fujitsu. Abomics has made a pilot agreement with Fujitsu, under which Fujitsu has trained its own personnel to demonstrate Abomics’ databases to its customers in Japanese hospitals. In December 2016 Abomics Oy signed an agreement with Synlab, the biggest provider of laboratory services in Europe, which has a presence in over 30 countries. Abomics is aiming for EUR 1 million turnover in 2017 and in two years time the target is already EUR 10 million. Website: